Researching the Channel Change

Courtesy of Roderick MacKinnon, Rockefeller University Playing gatekeeper to human health, channel proteins penetrate all cell membranes. In the nervous system, armies of channels open and close in precise order to create action potentials, the brief membrane depolarizations that act as the primary form of electrical signaling in animals. These action potentials prove so enduring, functioning properly even in extreme experimental preparations, that investigators might consider ion channels in

Written byMike May
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Playing gatekeeper to human health, channel proteins penetrate all cell membranes. In the nervous system, armies of channels open and close in precise order to create action potentials, the brief membrane depolarizations that act as the primary form of electrical signaling in animals. These action potentials prove so enduring, functioning properly even in extreme experimental preparations, that investigators might consider ion channels infallible. But, they are not.

An acquired channelopathy is a nonhereditary breakdown in a channel's function. "Acquired channelopathies arise from multiple causes at any developmental stage," says Jeffrey L. Noebels, Department of Neurology at Baylor College of Medicine, Houston. They develop in autoimmune diseases, such as Rasmussen encephalitis, in which antibodies cause seizures by binding to glutamate receptors. Many toxins also generate acquired channelopathies. An improperly prepared meal of puffer fish serves up tetrodotoxin, which blocks voltage-gated sodium channels. In some cases, environmental assaults even trigger changes in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies